What are the specifications of Mobosetinib capsules?

Mobocertinib Capsule strengths may vary by market and pharmaceutical company. Generally speaking, common strengths of mobocertinib are described in terms of the dosage of the drug. Mobocertinib capsules for oral administration contain the equivalent of 48.06mg of succinate ester of 40mg of mobocertinib without inactive ingredients.

Mobosetinib is a tyrosine kinase inhibitor (TKI) used to treat non-small cell lung cancer with specific EGFR gene mutations. Mobosetinib reduces the growth of non-small cell lung cancer by binding to and inhibiting EGFR exon 20 insertion mutations. Mobosetinib capsules may be used in adults with non-small cell lung cancer that has spread to other parts of the body (metastatic) and cannot be removed with surgery, whose disease has worsened during or after chemotherapy with platinum, and whose cancer has an epidermal growth factor receptor (EGFR) exon 20 insertion mutation.

Mobosetinib The original drug is currently on the market in China and has not yet been included in the medical insurance. SpecificationThe price of 40mg*112 pills per box is about 40,000 yuan, which is very expensive.The Hong Kong version of the original drug Specifications40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory40mg*120 pills per boxThe pricemay be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.